Immunoprecise Antibodies logo

Immunoprecise Antibodies Share Price Today (NASDAQ: IPA)

Immunoprecise Antibodies share price is $1.34 & ₹114.48 as on 4 Jul 2025, 01.29 hrs IST

$1.34

0.28

(26.42%)

Market is closed - opens 7 PM, 07 Jul 2025

View live Immunoprecise Antibodies share price in Dollar and Rupees. Guide to invest in Immunoprecise Antibodies stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Immunoprecise Antibodies, along with analyst recommendations, forecasts, and comprehensive financials.

Immunoprecise Antibodies share price movements

  • Today's Low: $1.09
    Today's High: $1.35

    Day's Volatility :19.26%

  • 52 Weeks Low: $0.27
    52 Weeks High: $1.34

    52 Weeks Volatility :79.85%

Immunoprecise Antibodies (IPA) Returns

PeriodImmunoprecise Antibodies LtdIndex (Russel 2000)
3 Months
224.1%
0.0%
6 Months
139.05%
0.0%
1 Year
31.0%
0.0%
3 Years
-66.75%
1.6%

Immunoprecise Antibodies (IPA) Key Statistics

in dollars & INR

Previous Close
$1.06
Open
$1.09
Today's High
$1.35
Today's Low
$1.09
Market Capitalization
$60.0M
Today's Volume
$2.7M
52 Week High
$1.35
52 Week Low
$0.27
Revenue TTM
$24.0M
EBITDA
$-12.5M
Earnings Per Share (EPS)
$-1.23
Profit Margin
-194.79%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-124.75%

How to invest in Immunoprecise Antibodies Stock (IPA) from India?

It is very easy for Indian residents to invest directly in Immunoprecise Antibodies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Immunoprecise Antibodies stock in both Indian Rupees (INR) and US Dollars (USD). Search for Immunoprecise Antibodies or IPA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Immunoprecise Antibodies or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Immunoprecise Antibodies shares which would translate to 0.638 fractional shares of Immunoprecise Antibodies as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Immunoprecise Antibodies, in just a few clicks!

Returns in Immunoprecise Antibodies (IPA) for Indian investors in Rupees

The Immunoprecise Antibodies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immunoprecise Antibodies investment value today

Current value as on today

₹1,36,332

Returns

₹36,332

(+36.33%)

Returns from Immunoprecise Antibodies Stock

₹34,000 (+34%)

Dollar Returns*

₹2,332 (+2.33%)

Indian investors sentiment towards Immunoprecise Antibodies (IPA)

4550.0%

Period: Jun 4, 2025 to Jul 4, 2025. Change in 30 Days versus previous period

Investment in Immunoprecise Antibodies Shares from India has grown by 4550.0% over the past 30 days, indicating increased transactional activity.

738%

Period: Jun 4, 2025 to Jul 4, 2025. Change in 30 Days versus previous period

Search interest for Immunoprecise Antibodies Stock from India on INDmoney has increased by 738% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Immunoprecise Antibodies

    Analyst Recommendation on Immunoprecise Antibodies

    Rating
    Trend

    Buy

      83%Buy

      16%Hold

      0%Sell

    Based on 6 Wall street analysts offering stock ratings for Immunoprecise Antibodies(by analysts ranked 0 to 5 stars)

    Analyst Forecast on Immunoprecise Antibodies Stock (IPA)

    What analysts predicted

    Upside of 198.51%

    Target:

    $4.00

    Current:

    $1.34

    Insights on Immunoprecise Antibodies Stock (Ticker Symbol: IPA)

    • Price Movement

      In the last 1 month, IPA stock has moved up by 86.6%
    • Increasing Revenue

      Revenue is up for the last 3 quarters, 5.26M → 6.15M (in $), with an average increase of 7.3% per quarter
    • Decreasing Net Profit

      Netprofit is down for the last 2 quarters, -2.55M → -21.52M (in $), with an average decrease of 743.0% per quarter
    • IPA vs ONC (1 yr)

      In the last 1 year, Beone Medicines Ltd has given 67.0% return, outperforming this stock by 36.0%
    • IPA vs ALNY (3 yr)

      In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 26.2% return, outperforming this stock by 93.0%
    • Price to Sales

      ForIPA every $1 of sales, investors are willing to pay $1.6, whereas for Beone Medicines Ltd, the investors are paying $6.3 for every $1 of sales.

    Immunoprecise Antibodies Technicals Summary

    Sell

    Neutral

    Buy

    Immunoprecise Antibodies is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

    Immunoprecise Antibodies (IPA) Vs Peers

    Returns
    Ratio's
    Overview
    Company Name1 Month6 Month1 Year3 Years5 Years
    Immunoprecise Antibodies Ltd logo
    86.61%
    139.05%
    31.0%
    -66.75%
    -91.8%
    Regeneron Pharmaceuticals, Inc. logo
    13.31%
    -23.58%
    -47.08%
    -7.99%
    -12.74%
    Beone Medicines Ltd logo
    -4.48%
    35.9%
    66.95%
    35.59%
    24.79%
    Vertex Pharmaceuticals Incorporated logo
    3.56%
    14.19%
    -3.15%
    57.86%
    57.78%
    Alnylam Pharmaceuticals, Inc. logo
    7.76%
    42.36%
    32.22%
    121.27%
    117.75%

    About Immunoprecise Antibodies

    ImmunoPrecise Antibodies Ltd. operates as a techbio company. It leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies; and support the discovery and development of therapeutic antibodies. The company's contract research organizations services include B cell Select platforms that enable antibody screening directly from B cells, facilitating the analysis of a set of antibodies, as well as for screening compared to traditional technologies; phage display services that are based on building custom immune libraries from various species; DeepDisplay, a technology utilizing a combination of transgenic animal platforms; bispecific Abthena technology; antibody humanization services; affinity maturation services; antibody development services; protein manufacturing; and cell line development services of target proteins or antibodies. It is also involved in the development and licensing of antibody discovery platforms and related IP assets. The company was founded in 1983 and is headquartered in Austin, Texas.
    Organization
    Immunoprecise Antibodies
    Employees
    72
    CEO
    Dr. Jennifer Lynne Bath Ph.D.
    Industry
    Miscellaneous

    Management People of Immunoprecise Antibodies

    NameTitle
    Dr. Jennifer Lynne Bath Ph.D.
    CEO, President & Non-Independent Director
    Dr. Ilse Roodink
    Chief Scientific Officer & Interim General Manager of IPA Europe, Oss
    Ms. Kari Graber
    Vice President of Commercial Services
    Mr. Joseph Scheffler
    Interim Chief Financial Officer

    Important FAQs about investing in IPA Stock from India :

    Can Indians buy Immunoprecise Antibodies shares?

    Yes, Indians can invest in the Immunoprecise Antibodies (IPA) from India.

    With INDmoney, you can buy Immunoprecise Antibodies at 0 brokerage. The step-by-step process is as follows:

    • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
    • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
    • Once funds are transferred successfully, you can buy Immunoprecise Antibodies at zero transaction cost.

    How can I buy Immunoprecise Antibodies shares from India?

    It is very easy to buy Immunoprecise Antibodies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

    Can Fractional shares of Immunoprecise Antibodies (IPA) be purchased?

    Yes, you can buy fractional shares of Immunoprecise Antibodies with INDmoney app.

    What are the documents required to start investing in Immunoprecise Antibodies stocks?

    To start investing in Immunoprecise Antibodies, You will need the following documents:

    • Proof of Identification (PAN, Aadhaar etc)
    • Proof of address (Aadhaar, Voter ID etc)

    These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

    What is Immunoprecise Antibodies share price today?

    Immunoprecise Antibodies share price today stands at $1.34, Open: $1.09 ; Previous Close: $1.06 ; High: $1.35 ; Low: $1.09 ; 52 Week High: $1.34 ; 52 Week Low: $0.27.

    The stock opens at $1.09, after a closing price of $1.06. The stock reached a daily high of $1.35 and a low of $1.09, with a 52-week high of $1.34 and a 52-week low of $0.27.

    What are today’s High and Low prices of Immunoprecise Antibodies Stock (IPA)?

    Today’s highest price of Immunoprecise Antibodies (IPA) is $1.35.

    Today’s lowest price of Immunoprecise Antibodies (IPA) is $1.09.

    What is the 52 Week High and Low Range of Immunoprecise Antibodies Stock (IPA)?

    • 52 Week High

      $1.34

    • 52 Week Low

      $0.27

    What are the historical returns of Immunoprecise Antibodies (IPA)?

    • 1 Month Returns

      86.61%

    • 3 Months Returns

      139.05%

    • 1 Year Returns

      31%

    • 5 Years Returns

      -91.8%

    What is today's market capitalisation of Immunoprecise Antibodies?

    Today's market capitalisation of Immunoprecise Antibodies IPA is 60.0M

    Who is the Chief Executive Officer (CEO) of Immunoprecise Antibodies ?

    Dr. Jennifer Lynne Bath Ph.D. is the current Chief Executive Officer (CEO) of Immunoprecise Antibodies.